A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics.

TitleA postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics.
Publication TypeJournal Article
Year of Publication2022
AuteursNicolas, G, Sévigny, M, Lecoquierre, F, Marguet, F, Deschênes, A, Del Pelaez, MCarment, Feuillette, S, Audebrand, A, Lecourtois, M, Rousseau, S, Richard, A-C, Cassinari, K, Deramecourt, V, Duyckaerts, C, Boland, A, Deleuze, J-F, Meyer, V, Echavarria, JClarimon, Gelpi, E, Akiyama, H, Hasegawa, M, Kawakami, I, Wong, TH, van Rooij, JGJ, van Swieten, JC, Campion, D, Dutchak, PA, Wallon, D, Lavoie-Cardinal, F, Laquerrière, A, Rovelet-Lecrux, A, Sephton, CF
JournalActa Neuropathol Commun
Volume10
Issue1
Pagination20
Date Published2022 02 12
ISSN2051-5960
KeywordsBrain, Codon, Nonsense, Female, Frontotemporal Dementia, Haploinsufficiency, Humans, Middle Aged, Nerve Tissue Proteins, Neurons, RNA-Binding Protein FUS
Abstract

Frontotemporal dementia (FTD) is a heterogeneous clinical disorder characterized by progressive abnormalities in behavior, executive functions, personality, language and/or motricity. A neuropathological subtype of FTD, frontotemporal lobar degeneration (FTLD)-FET, is characterized by protein aggregates consisting of the RNA-binding protein fused in sarcoma (FUS). The cause of FTLD-FET is not well understood and there is a lack of genetic evidence to aid in the investigation of mechanisms of the disease. The goal of this study was to identify genetic variants contributing to FTLD-FET and to investigate their effects on FUS pathology. We performed whole-exome sequencing on a 50-year-old FTLD patient with ubiquitin and FUS-positive neuronal inclusions and unaffected parents, and identified a de novo postzygotic nonsense variant in the NCDN gene encoding Neurochondrin (NCDN), NM_014284.3:c.1206G > A, p.(Trp402*). The variant was associated with a ~ 31% reduction in full-length protein levels in the patient's brain, suggesting that this mutation leads to NCDN haploinsufficiency. We examined the effects of NCDN haploinsufficiency on FUS and found that depleting primary cortical neurons of NCDN causes a reduction in the total number of FUS-positive cytoplasmic granules. Moreover, we found that these granules were significantly larger and more highly enriched with FUS. We then examined the effects of a loss of FUS function on NCDN in neurons and found that depleting cells of FUS leads to a decrease in NCDN protein and mRNA levels. Our study identifies the NCDN protein as a likely contributor of FTLD-FET pathophysiology. Moreover, we provide evidence for a negative feedback loop of toxicity between NCDN and FUS, where loss of NCDN alters FUS cytoplasmic dynamics, which in turn has an impact on NCDN expression.

DOI10.1186/s40478-022-01314-x
Alternate JournalActa Neuropathol Commun
PubMed ID35151370
PubMed Central IDPMC8841087